TITLE

SELF-REPORTED ADHERENCE NOT RELIABLE

PUB. DATE
January 1999
SOURCE
AIDS Patient Care & STDs;Jan1999, Vol. 13 Issue 1, p59
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Reports that self-reporting of adherence to various anti-retroviral therapies is not a reliable method when used alone. Electronic monitoring of adherence.
ACCESSION #
1566834

 

Related Articles

  • Adherence Assessment to Highly Active Antiretroviral Therapy. Tsasis, Peter // AIDS Patient Care & STDs;Mar2001, Vol. 15 Issue 3, p109 

    Adherence to highly active antiretroviral therapy (HAART) is the outcome of a dynamic process of clinical and behavioral interactions. This article reviews factors influencing this process and provides suggestions to enhance adherence to HAART. Interventions to improve adherence to HAART should...

  • Adherence of Human Immunodeficiency Virus-Infected Patients to Antiretroviral Therapy. Singh, Nina; Berman, Stephen M.; Swindells, Susan; Justis, Janice C.; Mohr, Jeffrey A.; Squier, Cheryl; Wagener, Marilyn M. // Clinical Infectious Diseases;10/1/1999, Vol. 29 Issue 4, p824 

    Presents a study which assessed the role of demographic, psychosocial and medical-regimen variables on adherence of HIV-infected patients to antiretroviral therapy. Characteristics of the patients; Data and methods used; Results and discussion.

  • HAART Adherence in Culturally Diverse Patients with HIV/AIDS: A Study of Male Patients from a... Kemppainen, Jeanne K.; Levine, Roger E.; Mistal, Mark; Schmidgall, Donald // AIDS Patient Care & STDs;Mar2001, Vol. 15 Issue 3, p117 

    Identifies the factors influencing adherence to antiretroviral medication regimens in culturally diverse populations with HIV/AIDS related to age, ethnicity and intravenous drug use. Use of the critical incident technique to identify factors determining adherence; Patients most influenced by...

  • Treat HIv-1 Infected with at Least Two Antiretrovirals.  // Kidney;Sep/Oct99, Vol. 8 Issue 5, p203 

    Discusses an abstract of the article, entitled `Effect of hemodialysis and antiretroviral therapy on plasma viral load in HIV-1 infected hemodialysis patients,' by T.S. Ahuja, N. Niaz. A. Velasco and others.

  • VIRACEPT COMBINATIONS STUDIES.  // AIDS Patient Care & STDs;Jun98, Vol. 12 Issue 6, p495 

    Presents information on the fifth Conference on Retroviruses and Opportunistic Infections in Chicago in 1998. Summarization of the results from clinical trials of the drug Viracept; Use of the drug with other protease inhibitors and anti-human immunodeficiency virus (HIV) drugs; Evaluation of...

  • A Cohort Study of Nevirapine Tolerance in Clinical Practice: French Aquitaine Cohort, 1997--1999. Bonnet, F.; Lawson-Ayayi, S.; Thiébaut, R.; Ramanampamonjy, R.; Lacoste, D.; Bernard, N.; Malvy, D.; Bonarek, M.; Djossou, F.; Beylot, J.; Dabis, F.; Morlat, P. // Clinical Infectious Diseases;11/15/2002, Vol. 35 Issue 10, p1231 

    We performed a retrospective study to evaluate, under routine circumstances, the tolerance and immunovirological changes associated with antiretroviral regimens that contain nevirapine in 137 patients (88% were antiretroviral experienced). During a mean follow-up of 11 months, 33% of patients...

  • Stavudine Once Daily. Cheer, S.M.; Goa, K.L. // Drugs;2002, Vol. 62 Issue 18, p2667 

    â–´ Stavudine administered once daily is a nucleoside analogue reverse transcriptase inhibitor. â–´ The efficacy (reduction in viral load and increase in CD4+ lymphocyte counts from baseline) of stavudine once daily-containing triple therapy was similar to that of stavudine immediate...

  • Failure of a prospective trial to detect cytomegalovirus retinitis after initiation of highly... Uphold, Constance R.; Smith, Fran // AIDS Patient Care & STDs;Dec98, Vol. 12 Issue 12, p907 

    Determines the incidence of cytomegalovirus (CMV) retinis prior to and after initiation with highly active antiretroviral therapy (HAART). Decrease in viral loads and increase in CD4+ T-cell counts after starting HAART; Non-occurrence of CMV retinis among patients receiving HAART; Development...

  • T-20 SHOWS PROMISE.  // AIDS Patient Care & STDs;Mar1999, Vol. 13 Issue 3, p200 

    Reports on the results of the first multidose human trial of the antiretroviral T-20. Decrease in patients' viral load; Results of similar trials using triple-drug HAART and four-drug HAART.

Share

Other Topics